Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension

1 Nov 2014

Abstract excerpt

BACKGROUND: Heterogeneity in response to treatment of pulmonary arterial hypertension (PAH) is a major challenge to improving outcome in this disease. Although vasodilator-responsive PAH (VR-PAH) accounts for a minority of cases, VR-PAH has a pronounced response to calcium channel blockers and better survival than vasodilator-nonresponsive PAH (VN-PAH). We hypothesized that VR-PAH has a different molecular cause...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apelin-related biomedical research
Share to Phosphodiesterase function and regulation
Share to Pulmonary Hypertension Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25361553
DOI: 10.1161/circulationaha.114.013317

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial HypertensionPMID 25361553Read ↗

Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.Semantic proximity Read ↗

Machine learning-based revelation of GABBR1 and IQGAP2 as candidate biomarkers of pulmonary arterial hypertension and their correlation with immune infiltrationSemantic proximity Read ↗

CTRP7 as a Molecular Biomarker for Predicting Responsiveness to Pulmonary Vasodilators: Insights from Human and Animal Studies in Pulmonary Arterial HypertensionSemantic proximity Read ↗

Identification of candidate genes in scleroderma-related pulmonary arterial hypertension.Semantic proximity Read ↗

Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertensionSemantic proximity Read ↗

Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial HypertensionSemantic proximity Read ↗

Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSemantic proximity Read ↗

Gene Microarray Analysis of Peripheral Blood Cells in Pulmonary Arterial HypertensionSemantic proximity Read ↗

Using Omics to Understand and Treat Pulmonary Vascular DiseaseSemantic proximity Read ↗

Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.Semantic proximity Read ↗

Single-cell transcriptomics reveal diverging pathobiology and opportunities for precision targeting in scleroderma-associated versus idiopathic pulmonary arterial hypertensionSemantic proximity Read ↗

Identification of immune‐associated signatures and potential therapeutic targets for pulmonary arterial hypertensionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.